Alison S. Long - 15 Dec 2021 Form 4 Insider Report for Kaleido Biosciences, Inc.

Role
Chief Medical Officer
Signature
/s/ Alison S. Long
Issuer symbol
N/A
Transactions as of
15 Dec 2021
Net transactions value
$0
Form type
4
Filing time
16 Dec 2021, 16:18:49 UTC
Next filing
18 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KLDO Stock Option (Right to Buy) Award $0 +300,000 $0.000000 300,000 15 Dec 2021 Common Stock 300,000 $3.08 Direct F1
transaction KLDO Restricted Stock Units Award $0 +24,350 $0.000000 24,350 15 Dec 2021 Common Stock 24,350 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest on December 15, 2022, with the remainder vesting in 12 equal quarterly installments thereafter.
F2 Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
F3 The restricted stock units shall vest 100% on December 15, 2023.